Fig. 4From: Cost-effectiveness of edaravone dexborneol versus human urinary kallidinogenase for acute ischemic stroke in ChinaIncremental cost-effectiveness ratio scatterplot. GDP gross domestic product, QALY quality-adjusted life yearBack to article page